Company Zoetis Inc.

Company Zoetis Inc.

ZTS

US98978V1035

Pharmaceuticals

Analysts' Consensus

Equities

ZTS

US98978V1035

Pharmaceuticals

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Group companies

Sector

Sales per Business

Sales per region

Ratings for Zoetis Inc.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Veterinary Drugs

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Group companies

Sector

Sales per Business

Sales per region

Ratings for Zoetis Inc.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Veterinary Drugs

Market Closed - Nyse Other stock markets 04:00:02 2024-04-24 pm EDT			5-day change	1st Jan Change
150.9 ^USD	+0.88%		-1.40%	-23.55%

Apr. 23	Barclays Adjusts Zoetis' Price Target to $230 From $260, Keeps Overweight Rating	MT
Apr. 22	Jefferies Lowers Zoetis Price Target to $200 from $220	MT

Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows:

- pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%);

- livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%);

- other (1.1%).

Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%).

At the end of 2022, the group has 29 production sites worldwide.

The United States accounts for 53.4% of net sales.

Number of employees: 14,100

USD in Million	2022	Weight	2023	Weight	Delta
Parasiticides 22.8 %	1,860	23.0 %	1,947	22.8 %	+4.68%
Vaccines 20.7 %	1,718	21.3 %	1,771	20.7 %	+3.08%
Dermatology 16.7 %	1,329	16.4 %	1,427	16.7 %	+7.37%
Other Pharmaceuticals 15.0 %	1,043	12.9 %	1,280	15.0 %	+22.72%
Anti-infectives 12.4 %	1,081	13.4 %	1,057	12.4 %	-2.22%
Animal Health Diagnostics 4.4 %	353	4.4 %	376	4.4 %	+6.52%
Medicated Feed Additives 4.1 %	360	4.5 %	354	4.1 %	-1.67%
Other Non-pharmaceuticals 3.0 %	250	3.1 %	254	3.0 %	+1.60%
Contract Manufacturing and Human Health 0.9 %	86	1.1 %	78	0.9 %	-9.30%

USD in Million	2022	Weight	2023	Weight	Delta
United States 53.3 %	4,313	53.4 %	4,555	53.3 %	+5.61%
Other Emerging Markets 9.2 %	758	9.4 %	784	9.2 %	+3.43%
Other Developed Markets 6.0 %	468	5.8 %	512	6.0 %	+9.40%
Brazil 4.6 %	330	4.1 %	393	4.6 %	+19.09%
Australia 3.8 %	289	3.6 %	323	3.8 %	+11.76%
China 3.7 %	382	4.7 %	320	3.7 %	-16.23%
United Kingdom 3.2 %	235	2.9 %	277	3.2 %	+17.87%
Canada 3.0 %	238	2.9 %	255	3.0 %	+7.14%
Germany 2.4 %	176	2.2 %	202	2.4 %	+14.77%
Mexico 1.9 %	136	1.7 %	162	1.9 %	+19.12%
Japan 1.8 %	173	2.1 %	158	1.8 %	-8.67%
France 1.7 %	126	1.6 %	142	1.7 %	+12.70%
Chile 1.6 %	141	1.7 %	140	1.6 %	-0.71%
Spain 1.4 %	118	1.5 %	122	1.4 %	+3.39%
Italy 1.4 %	111	1.4 %	121	1.4 %	+9.01%
Global 0.9 %	86	1.1 %	78	0.9 %	-9.30%

Managers	Title	Age	Since
Kristin Peck CEO	Chief Executive Officer	52	11-12-31
Wetteny Joseph DFI	Director of Finance/CFO	52	21-05-31
Mike McFarland CTO	Chief Tech/Sci/R&D Officer	-	10-12-31
Robert Polzer CTO	Chief Tech/Sci/R&D Officer	56	14-12-31
Wafaa Mamilli CTO	Chief Tech/Sci/R&D Officer	56	19-12-31
Steven Frank IRC	Investor Relations Contact	-	15-02-28
William Dorsey PRN	Corporate Officer/Principal	-	-
Ester Banque PRN	Corporate Officer/Principal	-	23-07-09
Abhay Nayak PRN	Corporate Officer/Principal	-	-
Roxanne Lagano HRO	Human Resources Officer	59	12-09-30

Members of the board	Title	Age	Since
Michael McCallister CHM	Chairman	71	12-12-31
Louise Parent BRD	Director/Board Member	73	13-07-31
Robert Scully BRD	Director/Board Member	74	13-05-31
Kristin Peck CEO	Chief Executive Officer	52	11-12-31
Paul Bisaro BRD	Director/Board Member	63	15-04-30
Frank D'Amelio BRD	Director/Board Member	66	12-06-30
Sanjay Khosla BRD	Director/Board Member	71	13-05-31
Gregory Norden BRD	Director/Board Member	66	12-12-31
Vanessa Broadhurst BRD	Director/Board Member	55	22-07-24
Willie Reed BRD	Director/Board Member	69	14-03-03

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	500,471,090	455,877,565 ( 91.09 %)	43,523,885 ( 8.697 %)	91.09 %

Name	Equities	%	Valuation
Vanguard Fiduciary Trust Co. 8.809 %	40,334,966	8.809 %	6 825 M $
BlackRock Advisors LLC 5.887 %	26,955,898	5.887 %	4 561 M $
STATE STREET CORPORATION 4.220 %	19,322,219	4.220 %	3 270 M $
State Farm Investment Management Corp. 3.570 %	16,344,542	3.570 %	2 766 M $
Capital Research & Management Co. (International Investors) 3.205 %	14,676,576	3.205 %	2 483 M $
Merrill Lynch International 3.013 %	13,795,822	3.013 %	2 334 M $
T. Rowe Price International Ltd. 2.996 %	13,716,681	2.996 %	2 321 M $
AllianceBernstein LP 2.977 %	13,629,846	2.977 %	2 306 M $
Eaton Vance Management 2.689 %	12,312,949	2.689 %	2 083 M $
Geode Capital Management LLC 2.150 %	9,844,613	2.150 %	1 666 M $

Zoetis, Inc.

10 Sylvan Way

07054, Parsippany

+973 822 7000

http://www.zoetis.com

Name	Category and Sector
Pharmaq AS Pharmaq AS Pharmaceuticals: MajorHealth Technology PHARMAQ AS operates as a veterinary pharmaceutical company. It provides health products to the global aquaculture industry. The company was founded on July 23, 2004 and is headquartered in Overhalla, Norway.	Pharmaceuticals: Major
Zoetis India Ltd. Zoetis India Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2007, Zoetis India Ltd. is a subsidiary of Zoetis, Inc. that manufactures vaccines and injectable biologic medicines. The private company is based in Mumbai, India.	Pharmaceuticals: Major
Zoetis Treasury Center BV
Zoetis Belgium SA Zoetis Belgium SA BiotechnologyHealth Technology Part of Zoetis, Inc., Zoetis Belgium SA is a Belgian company that manufactures animal vaccines and prescription medicines. The private company is based in Louvain-La-Neuve, Belgium.	Biotechnology
Zoetis Singapore Pte Ltd.
Zoetis Vietnam LLC Zoetis Vietnam LLC Pharmaceuticals: MajorHealth Technology Zoetis Vietnam LLC engages in the distribution of medicine and vaccinations for pets and livestocks. The company was founded on August 16, 2013 and is headquartered in Ho Chi Minh City, Vietnam.	Pharmaceuticals: Major
Zoetis Pharmaceutical Research Pvt Ltd.
Zoetis Korea Ltd. Zoetis Korea Ltd. Pharmaceuticals: MajorHealth Technology Part of Zoetis, Inc., Zoetis Korea Ltd. is a South Korean company that manufactures veterinary medicinal preparations. The private company is located in South Korea.	Pharmaceuticals: Major
Pharmaq Vietnam Co. Ltd.
Zoetis Philippines, Inc.
Zoetis Ceská republika sro Zoetis Ceská republika sro BiotechnologyHealth Technology Part of Zoetis, Inc., Zoetis Ceská republika sro is a private company located in Czechia that specializes in researching, developing, manufacturing, and marketing medicines and vaccines for animals.	Biotechnology
Zoetis Biopharmaceutical Co. Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

150.9 USD

Average target price

215.2 USD

Spread / Average Target

+42.62%

Consensus

Estimates Revisions

Company calendar

	1st Jan change	Capi.
ZOETIS INC.	-23.55%	68.34B
ELANCO ANIMAL HEALTH INCORPORATED	-10.67%	6.64B
BLUESTAR ADISSEO COMPANY	+16.00%	3.41B
VIRBAC	+0.14%	3.21B
VIMIAN GROUP AB	+2.53%	1.46B
JINYU BIO-TECHNOLOGY CO., LTD.	-14.67%	1.38B
VETOQUINOL SA	-2.44%	1.25B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.	-27.57%	1.21B
WUHAN KEQIAN BIOLOGY CO.,LTD	-12.86%	1.13B
TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD.	-2.99%	1.03B

Veterinary Drugs

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Veterinary Drugs